JPM: Cipla Shapes Respiratory Build-Up
This article was originally published in Scrip
Executive Summary
Twenty-six per cent of Cipla's top 50 R&D projects currently underway are in the respiratory segment and the Indian firm aims to launch its own differentiated respiratory and oncology pipeline in the US in the "near future."